These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20718987)

  • 21. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
    Werner S; Mendoza A; Hilger RA; Erlacher M; Reichardt W; Lissat A; Konanz C; Uhl M; Niemeyer CM; Khanna C; Kontny U
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):19-31. PubMed ID: 17823799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.
    Rao DD; Jay C; Wang Z; Luo X; Kumar P; Eysenbach H; Ghisoli M; Senzer N; Nemunaitis J
    Mol Ther; 2016 Aug; 24(8):1412-22. PubMed ID: 27166877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurogenic potential of Ewing's sarcoma cells.
    Sugimoto T; Umezawa A; Hata J
    Virchows Arch; 1997 Jan; 430(1):41-6. PubMed ID: 9037314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
    Landuzzi L; De Giovanni C; Nicoletti G; Rossi I; Ricci C; Astolfi A; Scopece L; Scotlandi K; Serra M; Bagnara GP; Nanni P; Lollini PL
    Am J Pathol; 2000 Dec; 157(6):2123-31. PubMed ID: 11106584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Innovative Therapeutic Option for the Treatment of Skeletal Sarcomas: Elimination of Osteo- and Ewing's Sarcoma Cells Using Physical Gas Plasma.
    Jacoby JM; Strakeljahn S; Nitsch A; Bekeschus S; Hinz P; Mustea A; Ekkernkamp A; Tzvetkov MV; Haralambiev L; Stope MB
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary cutaneous extraskeletal Ewing's sarcoma].
    Kourda M; Chatti S; Sfia M; Kraiem W; Ben Brahim E
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):986-9. PubMed ID: 16446642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.
    Subbiah V; Naing A; Brown RE; Chen H; Doyle L; LoRusso P; Benjamin R; Anderson P; Kurzrock R
    PLoS One; 2011 Apr; 6(4):e18424. PubMed ID: 21494688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
    Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
    Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
    Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
    Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EWS Knockdown and Taxifolin Treatment Induced Differentiation and Removed DNA Methylation from p53 Promoter to Promote Expression of Puma and Noxa for Apoptosis in Ewing's Sarcoma.
    Hossain MM; Ray SK
    J Cancer Ther; 2014 Oct; 5(12):1092-1113. PubMed ID: 27547487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1.
    Oyama R; Kito F; Qiao Z; Sakumoto M; Noguchi R; Takahashi M; Toki S; Tanzawa Y; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):770-778. PubMed ID: 30324244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
    Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
    Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
    Hartman KR; Triche TJ; Kinsella TJ; Miser JS
    Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.
    Olmos D; Postel-Vinay S; Molife LR; Okuno SH; Schuetze SM; Paccagnella ML; Batzel GN; Yin D; Pritchard-Jones K; Judson I; Worden FP; Gualberto A; Scurr M; de Bono JS; Haluska P
    Lancet Oncol; 2010 Feb; 11(2):129-35. PubMed ID: 20036194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ewing's sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing's Sarcoma Study.
    Kissane JM; Askin FB; Foulkes M; Stratton LB; Shirley SF
    Hum Pathol; 1983 Sep; 14(9):773-9. PubMed ID: 6885037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ewing's sarcoma of the cervix, a diagnostic dilemma: a case report and review of the literature.
    Mashriqi N; Gujjarlapudi JK; Sidhu J; Zur M; Yalamanchili M
    J Med Case Rep; 2015 Nov; 9():255. PubMed ID: 26549660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.